J. Giraldes

Structural basis for macrolactonization by the pikromycin thioesterase

Janet L. Smith, D. Sherman, D. Akey, 2006, Nature chemical biology.

Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology Insight.

Y. Mishina, E. Martin, W. Shao, 2016, Journal of medicinal chemistry.

Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1.

Michael D. Jones, B. Firestone, R. Pagliarini, 2017, ACS medicinal chemistry letters.

"Addition" and "Subtraction": Selectivity Design for Type II Maternal Embryonic Leucine Zipper Kinase Inhibitors.

W. Shao, J. Duca, K. Hurov, 2017, Journal of medicinal chemistry.

Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer.

Sarah L. Williams, W. Sellers, Z. Deng, 2020, Journal of medicinal chemistry.

Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors.

Paul N. Mortenson, M. Congreve, R. Cheng, 2012, ACS medicinal chemistry letters.

Structural and mechanistic insights into polyketide macrolactonization from polyketide-based affinity labels

Janet L. Smith, D. Sherman, D. Akey, 2006, Nature chemical biology.